In AMI, both HDAC1 and HDAC2 showed a trend of increase in the infarcted myocardium (Figure 1 A).
← all excerpts
HDAC class I inhibitor, Mocetinostat, reverses cardiac fibrosis in heart failure and diminishes CD90+ cardiac myofibroblast activation.
1
—
—